Visceral Leishmaniasis
Epidemiology of visceral leishmaniasis
8
The Dog as a Risk Factor in Transmission of Visceral Leishmaniasis: A Review
11
Antigen specific immunosuppression in visceral leishmaniasis is cell mediated
6
Multicomponent Chimeric Antigen for Serodiagnosis of Canine Visceral Leishmaniasis
6
Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
21
Immunomodulatory therapy of visceral leishmaniasis in HIV coinfected patients
17
Revisiting area risk classification of visceral leishmaniasis in Brazil
9
Disorganization of spleen compartments and dermatitis in canine visceral leishmaniasis
8
Comorbid infections induce progression of visceral leishmaniasis
12
Visceral leishmaniasis in 26 HIV negative adults
5
Tissue Cytokine Responses in Canine Visceral Leishmaniasis
5
Quantification of the natural history of visceral leishmaniasis and consequences for control
13
Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
6
Visceral Leishmaniasis with Endobronchial Involvement in an Immunocompetent Adult
6
An Overview of theLaboratory Diagnostic Procedures of Visceral Leishmaniasis (Kala-Azar)
11
Anti-Leishmania infantum IgG Antibody Avidity in Visceral Leishmaniasis
6
KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
7
Skin parasite landscape determines host infectiousness in visceral leishmaniasis
12
Application of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs
7
Immunodiagnosis of Visceral Leishmaniasis: Current Status and Challenges: A Review Article
11